1. Home
  2. RFI vs MGTX Comparison

RFI vs MGTX Comparison

Compare RFI & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Total Return Realty Fund Inc.

RFI

Cohen & Steers Total Return Realty Fund Inc.

N/A

Current Price

$11.01

Market Cap

293.3M

Sector

Finance

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$12.85

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RFI
MGTX
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.3M
1.2B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RFI
MGTX
Price
$11.01
$12.85
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$24.57
AVG Volume (30 Days)
79.4K
699.6K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
8.25%
N/A
EPS Growth
N/A
33.02
EPS
N/A
1.30
Revenue
N/A
$81,391,000.00
Revenue This Year
N/A
$141.38
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.20
Revenue Growth
N/A
144.57
52 Week Low
$10.78
$6.62
52 Week High
$12.17
$15.35

Technical Indicators

Market Signals
Indicator
RFI
MGTX
Relative Strength Index (RSI) 29.19 41.39
Support Level $10.86 $12.39
Resistance Level $11.38 $15.33
Average True Range (ATR) 0.13 0.65
MACD -0.04 -0.21
Stochastic Oscillator 0.00 7.69

Price Performance

Historical Comparison
RFI
MGTX

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: